Shares of Aurora Cannabis Inc. (NYSE:ACB – Get Rating) have been assigned an average recommendation of “Hold” from the seven research firms that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $2.30.
Several research firms recently weighed in on ACB. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a report on Wednesday, September 21st. Atb Cap Markets upgraded shares of Aurora Cannabis from an “underperform” rating to a “sector perform” rating in a research note on Thursday, September 22nd. Piper Sandler dropped their price target on shares of Aurora Cannabis from $2.00 to $1.00 in a research note on Wednesday, December 28th. Finally, Canaccord Genuity Group raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st.